Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 45.71B | 44.99B | 46.59B | 46.70B | 47.27B | 50.68B |
Gross Profit | 4.31B | 3.60B | 3.54B | 3.75B | 3.53B | 4.12B |
EBITDA | 3.28B | 2.94B | 2.84B | 3.02B | 2.93B | 2.96B |
Net Income | 1.01B | 416.00M | 316.00M | 465.00M | 475.00M | 905.00M |
Balance Sheet | ||||||
Total Assets | 37.03B | 36.89B | 37.69B | 39.11B | 41.05B | 40.86B |
Cash, Cash Equivalents and Short-Term Investments | 2.10B | 1.97B | 2.23B | 1.84B | 2.94B | 3.33B |
Total Debt | 790.00M | 1.37B | 2.51B | 4.43B | 5.71B | 6.23B |
Total Liabilities | 11.41B | 11.88B | 13.21B | 14.99B | 17.20B | 17.82B |
Stockholders Equity | 25.35B | 24.73B | 24.16B | 23.78B | 23.56B | 22.72B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 985.00M | 2.43B | 217.00M | 216.00M | -1.02B |
Operating Cash Flow | 0.00 | 2.59B | 3.46B | 2.18B | 2.74B | 2.18B |
Investing Cash Flow | 0.00 | -1.27B | -918.00M | -1.98B | -2.40B | -3.06B |
Financing Cash Flow | 0.00 | -1.46B | -2.19B | -1.51B | -773.00M | 2.12B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥22.09B | 9.25 | 3.31% | 3.60% | 16.83% | ||
74 Outperform | ¥11.58B | 10.38 | 3.99% | 2.56% | 168.27% | ||
74 Outperform | ¥5.73B | 12.30 | 1.91% | 4.81% | -6.89% | ||
74 Outperform | ¥17.10B | 7.41 | 2.75% | 1.73% | -2.77% | ||
73 Outperform | ¥6.70B | 6.99 | 2.12% | 1.73% | -61.62% | ||
65 Neutral | $10.56B | 15.49 | 5.57% | 1.96% | 2.71% | -26.28% | |
63 Neutral | ¥3.49B | 32.31 | 0.87% | 0.09% | 76.84% |